Published August 2021 | Version v1
Journal article Metadata-only

ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations

Creators

  • 1. Duke Cancer Center, Department of Radiation Oncology, Duke Cancer Center, Durham, North Carolina (United States)
  • 2. Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston (United States)
  • 3. Cancer Center Genetics Program, Massachusetts General Hospital, Boston (United States)
  • 4. Department of Surgery, Massachusetts General Hospital, Boston (United States)
  • 5. Department of Radiation Oncology, Massachusetts General Hospital, Boston (United States)
  • 6. Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York (United States)
  • 7. Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York (United States)

Description

Advances in germline genetic testing have led to a surge in identification of ataxia-telangiectasia mutated (ATM) variant carriers among breast cancer patients, raising numerous questions regarding use of breast radiation therapy (RT) in this population.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2021.01.045

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2021.01.045;
PII
S036030162100119X;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
110
Journal Issue
5
Journal Page Range
p. 1373-1382
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53124717
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
GENETICS; MAMMARY GLANDS; NEOPLASMS; PATIENTS; RADIOTHERAPY; RECOMMENDATIONS
Descriptors DEC
BIOLOGY; BODY; DISEASES; GLANDS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.